Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$148.14

0.78 (0.53%)

, PG

Procter & Gamble

$91.89

0.82 (0.90%)

20:25
01/22/18
01/22
20:25
01/22/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.72... Procter & Gamble (PG), consensus $1.14... Verizon (VZ), consensus 88c... Kimberly-Clark (KMB), consensus $1.55... Travelers (TRV), consensus $1.59... Fifth Third Bancorp (FITB), consensus 48c... Huntington Bancshares (HBAN), consensus 26c... Waters (WAT), consensus $2.44.

JNJ

Johnson & Johnson

$148.14

0.78 (0.53%)

PG

Procter & Gamble

$91.89

0.82 (0.90%)

VZ

Verizon

$53.46

1.55 (2.99%)

KMB

Kimberly-Clark

$116.91

1.42 (1.23%)

TRV

Travelers

$139.35

1.5 (1.09%)

FITB

Fifth Third

$32.77

0.27 (0.83%)

HBAN

Huntington Bancshares

$16.03

0.22 (1.39%)

WAT

Waters

$214.77

4.05 (1.92%)

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 06

    Feb

  • 16

    Feb

  • 08

    Mar

JNJ Johnson & Johnson
$148.14

0.78 (0.53%)

01/04/18
RBCM
01/04/18
NO CHANGE
Target $54
RBCM
Outperform
Pacira price target raised to $54 from $50 at RBC Capital
RBC Capital analyst Randall Stanicky raised his price target on Pacira (PCRX) to $54 and kept his Outperform rating. Stanicky says his focus is on the company's expected pre-announcement for Q4 this week and his upcoming discussion with CEO Dave Stack on Monday regarding changes from CMS around unbundling of payments that could represent a game changing opportunity for the company's EXPAREL. The analyst notes that traction is building around Pacira's relationship with Johnson & Johnson (JNJ) on the ortho selling side, which marks about half of its revenue.
01/02/18
01/02/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) downgraded to Neutral from Overweight at JPMorgan with analyst Michael Weinstein saying he sees greater upside potential in other large cap names with J&J shares trading at 17.9 times his 2018 earnings estimate. 2. PG&E (PCG) downgraded to Sell from Neutral at Guggenheim and to Neutral from Buy at Goldman Sachs. Goldman analyst Michael Lapides saying resolution of claims from the California wildfires, if inverse condemnation is applied, could take years and "cash flow/balance sheet impacts could prove significant still." 3. Allstate (ALL) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Meyer Shields saying the company's margin expansion story has played out. 4. Cabot Oil & Gas (COG) downgraded two notches to Underperform from Outperform at Raymond James with analyst John Freeman citing valuation after "considerable" 2017 share outperformance. 5. Windstream (WIN) downgraded to Underweight from Neutral at JPMorgan with analyst Philip Cusick saying he sees fundamental business challenges continuing in both the near and long term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/02/18
JPMS
01/02/18
DOWNGRADE
Target $150
JPMS
Neutral
Johnson & Johnson downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Michael Weinstein downgraded Johnson & Johnson (JNJ) to Neutral with an unchanged price target of $150. The stock closed Friday down 81c to $139.72. The analyst sees greater upside potential in other large cap names with J&J shares trading at 17.9 times his 2018 earnings estimate. He remains "fundamentally bullish" on the company, however. Weinstein this morning upgraded both Abbott Laboratories (ABT) and Baxter International (BAX) to Overweight.
01/18/18
MSCO
01/18/18
NO CHANGE
Target $157
MSCO
Equal Weight
Zytiga ruling a headwind, but doesn't change J&J thesis, says Morgan Stanley
Morgan Stanley analyst David Lewis noted that Johnson & Johnson suffered an adverse Zytiga IPR ruling, which he calls an incremental headwind. However, he added that a possible earlier generic Zytiga entry is irrelevant to his net present value for J&J shares and doesn't change his view that its Pharma growth accelerates in 2018. Lewis keeps an Equal Weight rating and $157 price target on J&J shares.
PG Procter & Gamble
$91.89

0.82 (0.90%)

12/13/17
DBAB
12/13/17
INITIATION
Target $101
DBAB
Buy
Procter & Gamble initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Steve Powers started Procter & Gamble with a Buy rating and $101 price target. The company is well positioned after "finally" catching up with market realities," the analyst contends. He views the risk/reward as attractive at current share levels.
12/27/17
JEFF
12/27/17
NO CHANGE
JEFF
Nielsen shows improved two-week sales trends, says Jefferies
Jefferies analyst Kevin Grundy says two-week sales growth in U.S. Nielsen channels improved sequentially for key home and personal care companies Colgate-Palmolive (CL), Church & Dwight (CHD) and Clorox (CLX), as well as beverage companies Monster Beverage (MNST), Coca-Cola (KO) and Dr Pepper Snapple (DPS). While overall growth remains tepid, sequential improvement in December for consumer spending, including staples, has been more upbeat, Grundy tells investors in a research note titled "Party Like It's 1999? Not Quite, But US Nielsen HPC/Bevs 2-Week Data Improves." The analyst favors shares of Church & Dwight, Procter & Gamble (PG), Dr Pepper and Monster.
01/16/18
GSCO
01/16/18
UPGRADE
Target $88
GSCO
Neutral
Procter & Gamble upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jason English upgraded Procter & Gamble to Neutral and raised his price target for the shares to $88 from $83. The analyst no longer sees enough downside to estimates to drive material underperformance for the stock. he admits his expectation of a negative estimate revision cycle has failed to materialize.
01/16/18
01/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Buy from Neutral at Nomura Instinet with analyst Romit Shah saying with Broadcom's (AVGO) hostile takeover attempt now analogous to a "gun to the head," Qualcomm management is likely to more aggressively focus on driving shareholder value in order to remain a standalone franchise. 2. Twitter (TWTR) upgraded to Buy from Sell at Aegis with analyst Victor Anthony saying he believes 2018 will be an inflection point in owned and operated advertising for Twitter and he sees a return to double-digit growth in that area in 2019. 3. Procter & Gamble (PG) upgraded to Neutral from Sell at Goldman Sachs with analyst Jason English saying he no longer sees enough downside to estimates to drive material underperformance for the stock. 4. Northrop Grumman (NOC) and Curtiss-Wright (CW) were upgraded to Outperform from Market Perform at Wells Fargo. 5. Ciena (CIEN) was upgraded to Buy from Neutral at Goldman Sachs, while Adtran (ADTN) was upgraded to Neutral from Sell. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VZ Verizon
$53.46

1.55 (2.99%)

01/16/18
01/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Neutral at Macquarie with analyst Laurent Vasilescu citing weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. 2. Verizon (VZ) downgraded to Neutral from Buy at MoffettNathanson. 3. Lockheed Martin (LMT) and Rockwell Collins (COL) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Spirit Airlines (SAVE) downgraded to Hold from Buy at Stifel with analyst Joseph DeNardi saying he believes Spirit will benefit this year from an improving demand and revenue environment, but that its higher revenue risk relative to potential competitive responses to its expected capacity growth is not fully reflected in the stock at current levels. 5. Finisar (FNSR) downgraded to Sell from Neutral at Goldman Sachs with analyst Doug Clark saying risks of oversupply and competition are heating up in the optical component landscape. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/18
01/17/18
DOWNGRADE
Target $55

Equal Weight
With fewer likely buyers seen, Morgan Stanley cuts Dish to Equal Weight
As previously reported, Morgan Stanley analyst Benjamin Swinburne downgraded Dish Network (DISH) to Equal Weight from Overweight as he now sees fewer likely buyers of its assets than hoped. T-Mobile (TMUS) has acquired significant additional spectrum, reducing the potential for a Dish partnership, tax reform will help Verizon (VZ) as it moves further towards small cell deployments in lieu of adding new spectrum, and the FCC is also considering a new auction, Swinburne tells investors. Additionally, the DOJ challenge of AT&T's (T) Time Warner (TWX) deal suggests a more challenging M&A backdrop than assumed for AT&T, which he had viewed as potentially the most logical buyer of Dish's DBS assets, Swinburne added. With Dish beginning to spend on its network in 2018 to boot, Swinburne lowered his price target on the stock to $55 from $75.
01/22/18
HOWW
01/22/18
UPGRADE
HOWW
Outperform
Verizon upgraded to Outperform from Sector Perform at Scotia Howard Weil
01/22/18
01/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. U.S. Steel (X) upgraded to Neutral from Sell at Citi with analyst Alexander Hacking saying he sees steel prices better supported near-term and increased his EBITDA estimates. 2. Aflac (AFL) upgraded to Strong Buy from Outperform at Raymond James with analyst Gregory Peters citing relative shares underperformance since the recent article alleging fraud at the company. 3. Schlumberger (SLB) upgraded to Overweight from Neutral at Atlantic Equities. 4. Harley-Davidson (HOG) upgraded to Outperform from Market Perform at Wells Fargo with analyst Timothy Conder saying investors are not appreciating the benefits of tax reform to Harley-Davidson. 5. Verizon (VZ) upgraded to Outperform from Sector Perform at Scotia Howard Weil. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
KMB Kimberly-Clark
$116.91

1.42 (1.23%)

11/02/17
SOCG
11/02/17
UPGRADE
Target $131
SOCG
Buy
Kimberly-Clark upgraded to Buy from Hold at Societe Generale
Societe Generale analyst Lain Simpson upgraded Kimberly-Clark to Buy saying the sell-off in shares is overdone and maintained a $131 price target. The analyst said US price competition is intense and input costs are rising, but these issues are well known and expects the operational recovery to be a medium term story.
12/11/17
SBSH
12/11/17
DOWNGRADE
Target $113
SBSH
Sell
Kimberly-Clark downgraded to Sell from Neutral at Citi
Citi analyst Wendy Nicholson downgraded Kimberly-Clark to Sell and cut her price target for the shares to $113 from $124. The analyst lowered her estimates for 2018 and 2019 to reflect "stiff competition" Kimberly-Clark faces "in multiple categories in multiple markets." She sees 2018 being a tough year for the company and further downside in the shares.
12/11/17
12/11/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kimberly-Clark (KMB) downgraded to Sell from Neutral at Citi with analyst Wendy Nicholson citing "stiff competition" Kimberly-Clark faces "in multiple categories in multiple markets." 2. TSYS (TSS) downgraded to Neutral from Buy at Goldman Sachs with analyst James Schneider citing valuation with the shares approaching his unchanged price target of $80. 3. Paccar (PCAR) downgraded to Neutral from Overweight at JPMorgan with analyst Ann Duignan saying the North American Class 8 truck market is likely to peak in 2018 and Paccar's stock is likely to continue to see multiple compression. 4. Flowserve (FLS) downgraded to Hold from Buy at Stifel with analyst Nathan Jones saying he sees no near-term catalysts given his expectation of orders being flat to down in the fourth quarter. 5. Brixmor (BRX) downgraded to Neutral from Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/13/17
DBAB
12/13/17
INITIATION
Target $121
DBAB
Hold
Kimberly-Clark initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Steve Powers started Kimberly-Clark with a Hold rating and $121 price target. The analyst believes future competition may pressure the company's volumes and limit its ability to take price.
TRV Travelers
$139.35

1.5 (1.09%)

10/20/17
RBCM
10/20/17
NO CHANGE
Target $140
RBCM
Outperform
Travelers price target raised to $140 from $135 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on Travelers to $140 and kept his Outperform rating after Q3 earnings. Dwelle says the company remained profitable in spite of the recent headwinds of hurricane losses and asbestos-related charge. Looking ahead, the analyst expects Travelers margins to compare favorable to peers in 2018 given the management's constructive commentary on pricing trends.
10/23/17
ARGS
10/23/17
NO CHANGE
Target $145
ARGS
Buy
Travelers price target raised to $145 from $139 at Argus
Argus analyst Jacob Kilstein raised his price target on Travelers to $145 and kept a Buy rating following Q3 results. Kilstein cites upward momentum in share prices, favorable valuation relative to peers, and management's growth initiatives, forecasting gross margin expansion as the company raises prices on auto insurance and expands its data analytics. The analyst is also positive on Travelers shareholder returns, noting the recent 7% dividend hike and a $5B stock buyback.
12/04/17
GSCO
12/04/17
INITIATION
Target $124
GSCO
Sell
Travelers initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Yaron Kinar started Travelers with a Sell rating and $124 price target. The analyst sees the company's liability portfolio experiencing underwriting compression due to rising inflationary trends and weak pricing. Kinar does not believe consensus estimates and valuations appropriately reflect the earnings erosion and rising volatility in the company's commercial liability business.
01/09/18
BOFA
01/09/18
UPGRADE
BOFA
Buy
Travelers upgraded to Buy from Neutral at BofA/Merrill
FITB Fifth Third
$32.77

0.27 (0.83%)

10/02/17
BARD
10/02/17
DOWNGRADE
Target $24
BARD
Underperform
Fifth Third downgraded to Underperform from Neutral at Baird
Baird analyst David George downgraded Fifth Third to Underperform from Neutral as it has outperformed most banks in Q3 and now trades at a premium to peers. He thinks it will be difficult to reach Project North Star targets without macro help and that significant execution risk remains. George maintained his $24 price target on Fifth Third.
11/15/17
MSCO
11/15/17
NO CHANGE
MSCO
Morgan Stanley says higher SIFI threshold could benefit Comerica, CIT, Zions
After Senate Banking Committee Chairman Mike Crapo proposed a bill in the Senate that would effectively remove the SIFI threshold for banks under $250B, Morgan Stanley analyst Ken Zerbe estimated that banks with $50B-$100B in assets could see a 12% increase in 2020 EPS and a 15% bump in 2021. He sees the largest potential increase at Comerica (CMA), followed by CIT Group (CIT) and Zions Bancorp (ZION). Zerbe projects the least EPS benefit for SunTrust (STI), Regions Financial (RF), Ally Financial (ALLY) and Discover (DFS), he tells investors. Other banks he lists in his note as potentially impacted by SIFI and CCAR changes include Synchrony (SYF), M&T Bank (MTB), KeyCorp (KEY), Fifth Third (FITB), BB&T (BBT), Citizens Financial (CFG) and Huntington Bancshares (HBAN).
11/17/17
MACQ
11/17/17
DOWNGRADE
Target $26
MACQ
Underperform
Fifth Third downgraded to Underperform from Neutral at Macquarie
Macquarie analyst David Konrad downgraded Fifth Third to Underperform with a $26 price target due to below peer returns, lowered PTPP expectations, and valuation.
08/09/17
WELS
08/09/17
INITIATION
Target $27
WELS
Market Perform
Fifth Third resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Fifth Third with a Market Perform rating and $27 price target.
HBAN Huntington Bancshares
$16.03

0.22 (1.39%)

10/26/17
BMOC
10/26/17
DOWNGRADE
Target $14.5
BMOC
Market Perform
Huntington downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Lana Chan downgraded Huntington Bancshares (HBAN) to Market Perform citing slower near-term loan growth and "continued disappointment" on operating expenses following the company's Q3 results. The analyst lowered her price target for the shares to $14.50 from $15. Chan's top picks are now KeyCorp (KEY) and Signature Bank (SBNY).
09/27/17
DADA
09/27/17
NO CHANGE
DADA
Huntington Bancshares named top Midwest mid-cap bank at DA Davidson
DA Davidson analyst Kevin K. Reevey says that Huntington Bancshares (HBAN) is one of his "favorite Midwest-based banks as a value play." The analyst says that the economic environment in the company's home markets is strong, while its auto loan credit metrics rank fourth among the country's top 25 auto lenders. He ranks Huntington Bancshares as his second favorite mid-cap bank, trailing only TCF Financial (TCF).
09/14/17
BERN
09/14/17
UPGRADE
BERN
Outperform
KeyCorp upgraded to Outperform at Bernstein
As previously reported, Bernstein analyst Kevin St. Pierre upgraded KeyCorp (KEY) to Outperform from Market Perform as he believes there is more likely to be upside to his 2018-2020 estimates than downside. With the year to date underperformance of the stock, the analyst believes valuation is far more attractive than at the start of the year. St. Pierre also upgraded Citizens Financial (CFG) and Huntington Bancshares (HBAN) to Outperform.
WAT Waters
$214.77

4.05 (1.92%)

12/04/17
12/04/17
UPGRADE
Target $230

Equal Weight
Waters upgraded to Equal Weight at Morgan Stanley as share losses moderate
As previously reported, Morgan Stanley analyst Steve Beuchaw upgraded Waters to Equal Weight from Underweight after the firm's October lab survey indicated that Pharma R&D budgets will accelerate in 2018 and Waters' implied market share loss in Pharma labs has moderated. He also has updated his tax analysis to reflect the proposed elements of the House and Senate tax bills, noting that over 95% of the company's cash is held overseas and its "repatriation opportunity can no longer be overlooked." Beuchaw raised his price target on Waters shares to $230 from $207.
12/04/17
12/04/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra saying the current valuation overly discounts the company's heightened investment cycle given its e-commerce growth opportunities. 2. Waters (WAT) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Steve Beuchaw citing the firm's October lab survey indicated that Pharma R&D budgets will accelerate in 2018 and Waters' implied market share loss in Pharma labs has moderated. 3. Globus Medical (GMED) upgraded to Outperform from Market Perform at Wells Fargo with analyst Larry Biegelsen saying he likes the company's diversification strategy amid a "weak" spine market. 4. eBay (EBAY) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying the current consensus for Gross Merchandise Volume are conservative, as it will likely accelerate its growth rate in 2018. 5. Owens Corning (OC) upgraded to Top Pick from Outperform at RBC Capital with analyst Robert Wetenhall saying the rating change reflects his increased confidence in fiscal 2018 outlook, projecting a double-digit EBITDA growth rate and a robust free cash flow generation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/03/18
EVER
01/03/18
INITIATION
Target $198
EVER
In Line
Waters initiated with an In Line at Evercore ISI
Evercore ISI analyst Ross Muken initiated Waters with an In Line and $198 price target.
01/05/18
BTIG
01/05/18
INITIATION
Target $230
BTIG
Buy
Waters initiated with a Buy at BTIG
BTIG analyst Sung Ji Nam started Waters with a Buy rating and $230 price target. The analyst thinks the company is well positioned for continued solid growth in 2018.

TODAY'S FREE FLY STORIES

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

, CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

19:41
02/20/18
02/20
19:41
02/20/18
19:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Verisk…

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

FLR

Fluor

$58.04

0.41 (0.71%)

RAS

RAIT Financial

$0.44

-0.031 (-6.56%)

EVBN

Evans Bancorp

$40.95

-1.55 (-3.65%)

CATM

Cardtronics

$24.69

-0.59 (-2.33%)

LC

LendingClub

$4.13

0.18 (4.56%)

BYD

Boyd Gaming

$37.60

0.26 (0.70%)

TXRH

Texas Roadhouse

$56.91

-1.07 (-1.85%)

PTLA

Portola Pharmaceuticals

$48.22

0.53 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 15

    Mar

  • 04

    May

ANW

Aegean Marine

18:47
02/20/18
02/20
18:47
02/20/18
18:47
Earnings
Aegean Marine sees Q4 EPS (69c) with items, consensus 5c »

Q4 EPS was impacted by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANW

Aegean Marine

18:44
02/20/18
02/20
18:44
02/20/18
18:44
Hot Stocks
Aegean Marine to acquire H.E.C. Europe for approximately $367M »

Aegean Marine is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAHO

Tahoe Resources

$3.98

-0.15 (-3.63%)

18:31
02/20/18
02/20
18:31
02/20/18
18:31
Hot Stocks
Tahoe Resources announces results of PEA for la Arena II »

Tahoe Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

PCH

Potlatch

$51.95

-2.8 (-5.11%)

, DEL

Deltic Timber

$93.28

-5.17 (-5.25%)

18:22
02/20/18
02/20
18:22
02/20/18
18:22
Hot Stocks
Potlatch, Deltic Timber completer merger, change name to PotlatchDeltic »

PotlatchDeltic announced…

PCH

Potlatch

$51.95

-2.8 (-5.11%)

DEL

Deltic Timber

$93.28

-5.17 (-5.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

NGD

New Gold

$2.58

-0.05 (-1.90%)

17:59
02/20/18
02/20
17:59
02/20/18
17:59
Hot Stocks
New Gold sees FY18 consolidated gold production 525,000-595,000 ounces »

Sees FY18 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NGD

New Gold

$2.58

-0.05 (-1.90%)

17:57
02/20/18
02/20
17:57
02/20/18
17:57
Earnings
New Gold reports Q4 adjusted EPS 6c, consensus 1c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PSA

Public Storage

$186.31

-2.44 (-1.29%)

17:48
02/20/18
02/20
17:48
02/20/18
17:48
Earnings
Public Storage reports Q4 adjusted FFO $2.75, consensus $2.72 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HAIN

Hain Celestial

$34.68

-0.8 (-2.25%)

17:38
02/20/18
02/20
17:38
02/20/18
17:38
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial »

Hain Celestial says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ESNT

Essent Group

$46.84

-0.39 (-0.83%)

17:38
02/20/18
02/20
17:38
02/20/18
17:38
Syndicate
Breaking Syndicate news story on Essent Group »

Essent Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$10.57

0.34 (3.32%)

17:33
02/20/18
02/20
17:33
02/20/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Ditech »

Lion Point reports 26.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEN

Sientra

$11.21

0.08 (0.72%)

17:32
02/20/18
02/20
17:32
02/20/18
17:32
Syndicate
Sientra enters into $50M At-the-Market equity offering sales agreement »

Sientra entered into an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ENLK

EnLink Midstream Partners

$16.36

0.03 (0.18%)

17:30
02/20/18
02/20
17:30
02/20/18
17:30
Earnings
EnLink Midstream Partners reports Q4 EPS 10c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 02

    May

  • 01

    Aug

  • 07

    Nov

ENLC

EnLink Midstream

$16.90

0.15 (0.90%)

17:28
02/20/18
02/20
17:28
02/20/18
17:28
Earnings
EnLink Midstream reports Q4 EPS $1.12 with items, consensus 17c »

Reports Q revenue $1.76B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 02

    May

  • 01

    Aug

HAIN

Hain Celestial

$34.68

-0.8 (-2.25%)

17:23
02/20/18
02/20
17:23
02/20/18
17:23
Hot Stocks
Hain Celestial will look at divestitures and small acquisitions »

The company is presenting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

PGH

Pengrowth Energy

$0.73

0.0072 (0.99%)

17:17
02/20/18
02/20
17:17
02/20/18
17:17
Hot Stocks
Pengrowth Energy appoints Peter Sametz as CEO »

Pengrowth Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

$34.65

0.54 (1.58%)

17:15
02/20/18
02/20
17:15
02/20/18
17:15
Hot Stocks
Devon Energy sees accelerating growth in Delaware Basin in early FY18 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

FTK

Flotek

$5.59

0.06 (1.09%)

17:15
02/20/18
02/20
17:15
02/20/18
17:15
Earnings
Flotek reports Q4 EPS (15c), two estimate consensus 3c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 23

    Feb

  • 15

    May

RCII

Rent-A-Center

$8.93

-0.62 (-6.49%)

17:14
02/20/18
02/20
17:14
02/20/18
17:14
Hot Stocks
Rent-A-Center sees FY18 free cash flow if at least $130M »

As the Company remains in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DVN

Devon Energy

$34.65

0.53 (1.55%)

17:13
02/20/18
02/20
17:13
02/20/18
17:13
Hot Stocks
Breaking Hot Stocks news story on Devon Energy »

Devon Energy Three-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

RCII

Rent-A-Center

$8.93

-0.62 (-6.49%)

17:12
02/20/18
02/20
17:12
02/20/18
17:12
Earnings
Rent-A-Center reports Q4 EPS (41c) ex-items, consensus (7c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DVN

Devon Energy

$34.65

0.54 (1.58%)

17:12
02/20/18
02/20
17:12
02/20/18
17:12
Earnings
Devon Energy reports Q4 adjusted EPS 38c, consensus 63c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

GSS

Golden Star Resources

$0.73

-0.0013 (-0.18%)

17:07
02/20/18
02/20
17:07
02/20/18
17:07
Earnings
Golden Star Resources reports Q4 EPS 4c, consensus 2c »

Reports Q revenue $81.8M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RAS

RAIT Financial

$0.44

-0.031 (-6.56%)

17:04
02/20/18
02/20
17:04
02/20/18
17:04
Hot Stocks
RAIT Financial concludes strategic, alternative review process »

RAIT Financial Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$76.46

-1.14 (-1.47%)

17:02
02/20/18
02/20
17:02
02/20/18
17:02
Hot Stocks
MSA Safety expects tailwind from U.S. tax reform during FY18 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 12

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.